Presentation is loading. Please wait.

Presentation is loading. Please wait.

Juan A. Crestanello, MD, Richard C. Daly, MD 

Published byHortense Melton Modified over 5 years ago

Similar presentations

Presentation on theme: "Juan A. Crestanello, MD, Richard C. Daly, MD "— Presentation transcript:

1 The Surgical Treatment for Ischemic Heart Failure trial: A landmark study 
Juan A. Crestanello, MD, Richard C. Daly, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 157, Issue 3, Pages (March 2019) DOI: /j.jtcvs Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Factors that influence the decision between coronary artery bypass grafting (CABG) and optimal medical therapy versus optimal medical therapy alone. LVEF, Left ventricular ejection fraction; LVESVI, left ventricle end systolic volume index. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

3 Factors that influence the decision between coronary artery bypass grafting (CABG) and optimal medical therapy. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Juan A. Crestanello, MD, Richard C. Daly, MD "

Similar presentations

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction 

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction 
The “occasional open heart surgeon” revisited

The “occasional open heart surgeon” revisited
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Technological innovation in cardiothoracic surgery: A pragmatist's approach  Pedro J. del Nido, MD  The Journal of Thoracic and Cardiovascular Surgery 

Technological innovation in cardiothoracic surgery: A pragmatist's approach  Pedro J. del Nido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Myocardial bridging over the left anterior descending: Myotomy, bypass, or both?  Chigozirim N. Ekeke, BS, Stephen Noble, MD, Ernest Mazzaferri, MD, Juan.

Myocardial bridging over the left anterior descending: Myotomy, bypass, or both?  Chigozirim N. Ekeke, BS, Stephen Noble, MD, Ernest Mazzaferri, MD, Juan.
Juan C. Araque, MD, Kevin L. Greason, MD, Zhuo Li, MS, Courtney N

Juan C. Araque, MD, Kevin L. Greason, MD, Zhuo Li, MS, Courtney N
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 

Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction 

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction 
Right internal thoracic artery or saphenous vein grafting

Right internal thoracic artery or saphenous vein grafting
Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice?  Yang Liu,

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice?  Yang Liu,
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials  Hisato Takagi, MD, PhD,

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials  Hisato Takagi, MD, PhD,
A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results  Ho Young.

A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results  Ho Young.
Defining operative mortality: Impact on outcome reporting

Defining operative mortality: Impact on outcome reporting
Why surgery won the SYNTAX trial and why it matters

Why surgery won the SYNTAX trial and why it matters
J. Bonatti, MD, T. Schachner, MD, N. Bonaros, MD, A. Öhlinger, MD, M

J. Bonatti, MD, T. Schachner, MD, N. Bonaros, MD, A. Öhlinger, MD, M

Similar presentations

Ads by Google